These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28536823)

  • 21. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
    Radhakrishna SM; Grimm A; Broderick L
    BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome.
    Kuemmerle-Deschner JB; Tyrrell PN; Koetter I; Wittkowski H; Bialkowski A; Tzaribachev N; Lohse P; Koitchev A; Deuter C; Foell D; Benseler SM
    Arthritis Rheum; 2011 Mar; 63(3):840-9. PubMed ID: 21360513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of interleukin-1 receptor antagonist responsive to anakinra.
    Schnellbacher C; Ciocca G; Menendez R; Aksentijevich I; Goldbach-Mansky R; Duarte AM; Rivas-Chacon R
    Pediatr Dermatol; 2013; 30(6):758-60. PubMed ID: 22471702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pearls from the Third Israeli Conference on FMF, other autoinflammatory disorders and AA amyloidosis.
    Livneh A; Ben-Zvi I
    Isr Med Assoc J; 2014 May; 16(5):269-70. PubMed ID: 24979827
    [No Abstract]   [Full Text] [Related]  

  • 25. Kidney Transplant in a Patient With Tumor Necrosis Factor Receptor-1 Syndrome (TRAPS): Case Report and Review of the Literature.
    Rodziewicz N; Bhushan S; Avasia A; Singh N
    Transplant Proc; 2016; 48(1):265-6. PubMed ID: 26915881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra.
    Brau-Javier CN; Gonzales-Chavez J; Toro JR
    Arch Dermatol; 2012 Mar; 148(3):301-4. PubMed ID: 22431772
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
    Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
    Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoinflammation in 2010: expanding clinical spectrum and broadening therapeutic horizons.
    Ombrello MJ; Kastner DL
    Nat Rev Rheumatol; 2011 Feb; 7(2):82-4. PubMed ID: 21289614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
    Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
    Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.
    Sterba G; Sterba Y
    Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.
    Rossi-Semerano L; Piram M; Chiaverini C; De Ricaud D; Smahi A; Koné-Paut I
    Pediatrics; 2013 Oct; 132(4):e1043-7. PubMed ID: 24019411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature.
    Cantarini L; Rigante D; Lucherini OM; Cimaz R; Laghi Pasini F; Baldari CT; Benucci M; Simonini G; Di Sabatino V; Brizi MG; Galeazzi M
    Int J Immunopathol Pharmacol; 2010; 23(3):701-7. PubMed ID: 20943039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
    Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
    Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe acne in autoinflammatory diseases].
    Faleri S; Feichtner K; Ruzicka T
    Hautarzt; 2016 Nov; 67(11):897-901. PubMed ID: 27448064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
    de Koning HD; Schalkwijk J; van der Meer JW; Simon A
    J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363
    [No Abstract]   [Full Text] [Related]  

  • 36. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L; Marchetti F; Tommasini A; Ventura A
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment.
    Van Nieuwenhove E; De Langhe E; Dooley J; Van Den Oord J; Shahrooei M; Parvaneh N; Ziaee V; Savic S; Kacar M; Bossuyt X; Humblet-Baron S; Liston A; Wouters C
    Rheumatology (Oxford); 2021 Nov; 60(11):5436-5446. PubMed ID: 33693560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.